Tvardi Therapeutics, Inc. (TVRD) Stock Analysis

Tvardi Therapeutics, Inc. (TVRD) is a publicly traded company in the HEALTHCARE sector. It trades at $3.17, carries a market capitalization of $31.71M. This page summarizes the public market data, fundamentals, and frequently asked questions for TVRD, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.17
• Market Cap: $31.71M
• EPS: $-0.27
• 52-Week High: $43.65
• 52-Week Low: $2.75

About Tvardi Therapeutics, Inc.

None

GNG Research Analysis

GNG Research scores Tvardi Therapeutics, Inc. (TVRD) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TVRD.

Frequently Asked Questions

Does TVRD pay dividends?

Tvardi Therapeutics, Inc. (TVRD) does not currently pay a regular dividend.

What is TVRD's market cap?

Tvardi Therapeutics, Inc. (TVRD) has a market capitalization of $31.71M with a current stock price of $3.17.